Form 8-K - Current report:
SEC Accession No. 0001104659-23-037343
Filing Date
2023-03-28
Accepted
2023-03-28 06:31:15
Documents
12
Period of Report
2023-03-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310453d1_8k.htm   iXBRL 8-K 24971
  Complete submission text file 0001104659-23-037343.txt   196687

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA twst-20230323.xsd EX-101.SCH 3055
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE twst-20230323_lab.xml EX-101.LAB 34477
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE twst-20230323_pre.xml EX-101.PRE 22610
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2310453d1_8k_htm.xml XML 3479
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38720 | Film No.: 23766097
SIC: 2836 Biological Products, (No Diagnostic Substances)